{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:54:05Z","timestamp":1792072445405,"version":"4.4.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1RF1NS110354-01"],"award-info":[{"award-number":["1RF1NS110354-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0264"],"award-info":[{"award-number":["W81XWH-19-1-0264"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","award":["PF-RCE-1946"],"award-info":[{"award-number":["PF-RCE-1946"]}],"id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-020160"],"award-info":[{"award-number":["MJFF-020160"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-63444-9","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:09:34Z","timestamp":1758888574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Synaptic vesicle endocytosis deficits underlie cognitive dysfunction in mouse models of GBA-linked Parkinson\u2019s disease and dementia with Lewy bodies"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0974-0307","authenticated-orcid":false,"given":"D. J.","family":"Vidyadhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-2475","authenticated-orcid":false,"given":"David","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risha","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapeng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-1733","authenticated-orcid":false,"given":"Sreeganga. S.","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"63444_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","volume":"33","author":"G Bultron","year":"2010","unstructured":"Bultron, G. et al. The risk of Parkinson\u2019s disease in type 1 Gaucher disease. J. Inherit. Metab. Dis. 33, 167\u2013173 (2010).","journal-title":"J. Inherit. Metab. Dis."},{"key":"63444_CR2","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky, E. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N. Engl. J. Med. 361, 1651\u20131661 (2009).","journal-title":"N. Engl. J. Med."},{"key":"63444_CR3","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz, J., Rosenbaum, H. & Gershoni-Baruch, R. Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N. Engl. J. Med. 351, 1972\u20131977 (2004).","journal-title":"N. Engl. J. Med."},{"key":"63444_CR4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1001\/jamaneurol.2016.1593","volume":"73","author":"T Shiner","year":"2016","unstructured":"Shiner, T. et al. High frequency of GBA gene mutations in dementia with Lewy bodies among Ashkenazi Jews. JAMA Neurol. 73, 1448\u20131453 (2016).","journal-title":"JAMA Neurol."},{"key":"63444_CR5","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","volume":"79","author":"D Tsuang","year":"2012","unstructured":"Tsuang, D. et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology 79, 1944\u20131950 (2012).","journal-title":"Neurology"},{"key":"63444_CR6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/brain\/awu002","volume":"137","author":"M Siebert","year":"2014","unstructured":"Siebert, M., Sidransky, E. & Westbroek, W. Glucocerebrosidase is shaking up the synucleinopathies. Brain 137, 1304\u20131322 (2014).","journal-title":"Brain"},{"key":"63444_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"63444_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ana.24781","volume":"80","author":"G Liu","year":"2016","unstructured":"Liu, G. et al. Specifically neuropathic Gaucher\u2019s mutations accelerate cognitive decline in Parkinson\u2019s. Ann. Neurol. 80, 674\u2013685 (2016).","journal-title":"Ann. Neurol."},{"key":"63444_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mds.26359","volume":"31","author":"IF Mata","year":"2016","unstructured":"Mata, I. F. et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson\u2019s disease. Mov. Disord. 31, 95\u2013102 (2016).","journal-title":"Mov. Disord."},{"key":"63444_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJM198703053161002","volume":"316","author":"S Tsuji","year":"1987","unstructured":"Tsuji, S. et al. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher\u2019s disease. N. Engl. J. Med. 316, 570\u2013575 (1987).","journal-title":"N. Engl. J. Med."},{"key":"63444_CR11","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1073\/pnas.85.7.2349","volume":"85","author":"S Tsuji","year":"1988","unstructured":"Tsuji, S. et al. Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc. Natl. Acad. Sci. USA 85, 2349\u20132352 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63444_CR12","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","volume":"160","author":"J Charrow","year":"2000","unstructured":"Charrow, J. et al. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch. Intern. Med. 160, 2835\u20132843 (2000).","journal-title":"Arch. Intern. Med."},{"key":"63444_CR13","unstructured":"Grabowski, G. A., Petsko, G. A. & Kolodny, E. H. Gaucher disease. in The Online Metabolic and Molecular Bases of Inherited Disease (eds Valle, D. L., Antonarakis, S., Ballabio, A., Beaudet, A. L. & Mitchell, G. A) (McGraw-Hill Education, 2019)."},{"key":"63444_CR14","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","volume":"71","author":"RN Alcalay","year":"2014","unstructured":"Alcalay, R. N. et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 71, 752\u2013757 (2014).","journal-title":"JAMA Neurol."},{"key":"63444_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.26071","volume":"30","author":"K Brockmann","year":"2015","unstructured":"Brockmann, K. et al. GBA-associated Parkinson\u2019s disease: reduced survival and more rapid progression in a prospective longitudinal study. Mov. Disord. 30, 407\u2013411 (2015).","journal-title":"Mov. Disord."},{"key":"63444_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/brain\/aws318","volume":"136","author":"SE Winder-Rhodes","year":"2013","unstructured":"Winder-Rhodes, S. E. et al. Glucocerebrosidase mutations influence the natural history of Parkinson\u2019s disease in a community-based incident cohort. Brain 136, 392\u2013399 (2013).","journal-title":"Brain"},{"key":"63444_CR17","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1016\/j.neurobiolaging.2015.08.027","volume":"36","author":"T Oeda","year":"2015","unstructured":"Oeda, T. et al. Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson\u2019s disease. Neurobiol. Aging 36, 3306\u20133313 (2015).","journal-title":"Neurobiol. Aging"},{"key":"63444_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.28932","volume":"37","author":"AA Szwedo","year":"2022","unstructured":"Szwedo, A. A. et al. GBA and APOE impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study. Mov. Disord. 37, 1016\u20131027 (2022).","journal-title":"Mov. Disord."},{"key":"63444_CR19","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awv179","volume":"138","author":"RN Alcalay","year":"2015","unstructured":"Alcalay, R. N. et al. Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations. Brain 138, 2648\u20132658 (2015).","journal-title":"Brain"},{"key":"63444_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/acn3.177","volume":"2","author":"EM Rocha","year":"2015","unstructured":"Rocha, E. M. et al. Progressive decline of glucocerebrosidase in aging and Parkinson\u2019s disease. Ann. Clin. Transl. Neurol. 2, 433\u2013438 (2015).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"63444_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neurobiolaging.2018.02.028","volume":"67","author":"PJ Hallett","year":"2018","unstructured":"Hallett, P. J. et al. Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain. Neurobiol. Aging 67, 189\u2013200 (2018).","journal-title":"Neurobiol. Aging"},{"key":"63444_CR22","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1750-3639.2010.00373.x","volume":"20","author":"GS Watson","year":"2010","unstructured":"Watson, G. S. & Leverenz, J. B. Profile of cognitive impairment in Parkinson\u2019s disease. Brain Pathol. 20, 640\u2013645 (2010).","journal-title":"Brain Pathol."},{"key":"63444_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"ME Gegg","year":"2012","unstructured":"Gegg, M. E. et al. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann. Neurol. 72, 455\u2013463 (2012).","journal-title":"Ann. Neurol."},{"key":"63444_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuron.2017.12.012","volume":"97","author":"F Zunke","year":"2018","unstructured":"Zunke, F. et al. Reversible conformational conversion of \u03b1-synuclein into toxic assemblies by glucosylceramide. Neuron 97, 92\u2013107.e110 (2018).","journal-title":"Neuron"},{"key":"63444_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli, J. R. et al. Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37\u201352 (2011).","journal-title":"Cell"},{"key":"63444_CR26","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","volume":"37","author":"YV Taguchi","year":"2017","unstructured":"Taguchi, Y. V. et al. Glucosylsphingosine promotes \u03b1-synuclein pathology in mutant GBA-associated Parkinson\u2019s disease. J. Neurosci. 37, 9617\u20139631 (2017).","journal-title":"J. Neurosci."},{"key":"63444_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000523","volume":"6","author":"L Straniero","year":"2020","unstructured":"Straniero, L. et al. The SPID-GBA study: sex distribution, penetrance, incidence, and dementia in GBA-PD. Neurol. Genet. 6, e523 (2020).","journal-title":"Neurol. Genet."},{"key":"63444_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112231","volume":"42","author":"DJ Vidyadhara","year":"2023","unstructured":"Vidyadhara, D. J. et al. Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson\u2019s disease. Cell Rep. 42, 112231 (2023).","journal-title":"Cell Rep."},{"key":"63444_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra, S., Gallardo, G., Fern\u00e1ndez-Chac\u00f3n, R., Schl\u00fcter, O. M. & S\u00fcdhof, T. C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123, 383\u2013396 (2005).","journal-title":"Cell"},{"key":"63444_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2320064121","volume":"121","author":"N Wang","year":"2024","unstructured":"Wang, N. et al. Decoding transcriptomic signatures of cysteine string protein alpha-mediated synapse maintenance. Proc. Natl. Acad. Sci. USA 121, e2320064121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63444_CR31","doi-asserted-by":"publisher","unstructured":"Zhu, B. et al. Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease Brains. bioRxiv https:\/\/doi.org\/10.1101\/2022.02.14.480397 (2022).","DOI":"10.1101\/2022.02.14.480397"},{"key":"63444_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s40478-024-01803-1","volume":"12","author":"EK Shwab","year":"2024","unstructured":"Shwab, E. K. et al. Single-nucleus multi-omics of Parkinson\u2019s disease reveals a glutamatergic neuronal subtype susceptible to gene dysregulation via alteration of transcriptional networks. Acta Neuropathol. Commun. 12, 111 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"63444_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47027-8","volume":"15","author":"TM Goralski","year":"2024","unstructured":"Goralski, T. M. et al. Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nat. Commun. 15, 2642 (2024).","journal-title":"Nat. Commun."},{"key":"63444_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-024-00672-8","volume":"10","author":"HM Geertsma","year":"2024","unstructured":"Geertsma, H. M. et al. A topographical atlas of \u03b1-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs. NPJ Parkinsons Dis. 10, 65 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"63444_CR35","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/cne.23901","volume":"524","author":"K Taguchi","year":"2016","unstructured":"Taguchi, K., Watanabe, Y., Tsujimura, A. & Tanaka, M. Brain region-dependent differential expression of alpha-synuclein. J. Comp. Neurol. 524, 1236\u20131258 (2016).","journal-title":"J. Comp. Neurol."},{"key":"63444_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00429-017-1504-1","volume":"223","author":"IG Dopeso-Reyes","year":"2018","unstructured":"Dopeso-Reyes, I. G. et al. Glucocerebrosidase expression patterns in the non-human primate brain. Brain Struct. Funct. 223, 343\u2013355 (2018).","journal-title":"Brain Struct. Funct."},{"key":"63444_CR37","doi-asserted-by":"publisher","first-page":"e0138107","DOI":"10.1371\/journal.pone.0138107","volume":"10","author":"D Herrera Moro Chao","year":"2015","unstructured":"Herrera Moro Chao, D. et al. Visualization of active glucocerebrosidase in rodent brain with high spatial resolution following in situ labeling with fluorescent activity based probes. PLoS ONE 10, e0138107 (2015).","journal-title":"PLoS ONE"},{"key":"63444_CR38","doi-asserted-by":"crossref","unstructured":"Boddupalli, C. S. et al. Neuroinflammation in neuronopathic Gaucher disease: role of microglia and NK cells, biomarkers, and response to substrate reduction therapy. Elife 11, e79830 (2022).","DOI":"10.7554\/eLife.79830"},{"key":"63444_CR39","doi-asserted-by":"crossref","unstructured":"Banks, S. M. L. et al. Hsc70 ameliorates the vesicle recycling defects caused by excess \u03b1-synuclein at synapses. eNeuro 7, ENEURO.0448-19.2020 (2020).","DOI":"10.1523\/ENEURO.0448-19.2020"},{"key":"63444_CR40","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1523\/JNEUROSCI.3627-15.2016","volume":"36","author":"J Xu","year":"2016","unstructured":"Xu, J. et al. \u03b1-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals. J. Neurosci. 36, 4408\u20134414 (2016).","journal-title":"J. Neurosci."},{"key":"63444_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05597","volume":"4","author":"B Binotti","year":"2015","unstructured":"Binotti, B. et al. The GTPase Rab26 links synaptic vesicles to the autophagy pathway. Elife 4, e05597 (2015).","journal-title":"Elife"},{"key":"63444_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","volume":"4","author":"JG Goldman","year":"2018","unstructured":"Goldman, J. G. et al. Cognitive impairment in Parkinson\u2019s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. NPJ Parkinsons Dis. 4, 19 (2018).","journal-title":"NPJ Parkinsons Dis."},{"key":"63444_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107842","volume":"26","author":"X Cheng","year":"2023","unstructured":"Cheng, X. et al. Impaired pre-synaptic plasticity and visual responses in auxilin-knockout mice. iScience 26, 107842 (2023).","journal-title":"iScience"},{"key":"63444_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/bs.pbr.2022.01.006","volume":"269","author":"BW Balleine","year":"2022","unstructured":"Balleine, B. W. Animal models of action control and cognitive dysfunction in Parkinson\u2019s disease. Prog. Brain Res. 269, 227\u2013255 (2022).","journal-title":"Prog. Brain Res."},{"key":"63444_CR45","doi-asserted-by":"publisher","first-page":"745438","DOI":"10.3389\/fnagi.2021.745438","volume":"13","author":"Y Fan","year":"2021","unstructured":"Fan, Y. et al. Experimental models of cognitive impairment for use in Parkinson\u2019s disease research: the distance between reality and ideal. Front. Aging Neurosci. 13, 745438 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"63444_CR46","doi-asserted-by":"crossref","unstructured":"Decourt, M., Jim\u00e9nez-Urbieta, H., Benoit-Marand, M. & Fernagut, P. O. Neuropsychiatric and cognitive deficits in Parkinson\u2019s disease and their modeling in rodents. Biomedicines 9, 684 (2021).","DOI":"10.3390\/biomedicines9060684"},{"key":"63444_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1523\/JNEUROSCI.0680-22.2022","volume":"43","author":"CL Mahoney-Crane","year":"2023","unstructured":"Mahoney-Crane, C. L. et al. Neuronopathic GBA1L444P mutation accelerates glucosylsphingosine levels and formation of hippocampal alpha-synuclein inclusions. J. Neurosci. 43, 501\u2013521 (2023).","journal-title":"J. Neurosci."},{"key":"63444_CR48","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ymgme.2017.11.001","volume":"122","author":"N Tayebi","year":"2017","unstructured":"Tayebi, N. et al. Glucocerebrosidase haploinsufficiency in A53T \u03b1-synuclein mice impacts disease onset and course. Mol. Genet Metab. 122, 198\u2013208 (2017).","journal-title":"Mol. Genet Metab."},{"key":"63444_CR49","doi-asserted-by":"crossref","unstructured":"Lado, W. et al. Synaptic and cognitive impairment associated with L444P heterozygous glucocerebrosidase mutation. Brain 148, 1621\u20131638 (2024).","DOI":"10.1093\/brain\/awae380"},{"key":"63444_CR50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","volume":"81","author":"A Lwin","year":"2004","unstructured":"Lwin, A., Orvisky, E., Goker-Alpan, O., LaMarca, M. E. & Sidransky, E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol. Genet. Metab. 81, 70\u201373 (2004).","journal-title":"Mol. Genet. Metab."},{"key":"63444_CR51","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1093\/brain\/awp161","volume":"132","author":"Z Gan-Or","year":"2009","unstructured":"Gan-Or, Z., Giladi, N. & Orr-Urtreger, A. Differential phenotype in Parkinson\u2019s disease patients with severe versus mild GBA mutations. Brain 132, e125 (2009).","journal-title":"Brain"},{"key":"63444_CR52","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","volume":"70","author":"Z Gan-Or","year":"2008","unstructured":"Gan-Or, Z. et al. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 70, 2277\u20132283 (2008).","journal-title":"Neurology"},{"key":"63444_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41531-023-00604-y","volume":"9","author":"MF Altay","year":"2023","unstructured":"Altay, M. F. et al. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. NPJ Parkinsons Dis. 9, 161 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"63444_CR54","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739\u201329752 (2006).","journal-title":"J. Biol. Chem."},{"key":"63444_CR55","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker, D. G. et al. Changes in properties of serine 129 phosphorylated \u03b1-synuclein with progression of Lewy-type histopathology in human brains. Exp. Neurol. 240, 190\u2013204 (2013).","journal-title":"Exp. Neurol."},{"key":"63444_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep05797","volume":"4","author":"JF Kellie","year":"2014","unstructured":"Kellie, J. F. et al. Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson\u2019s disease brain tissue by intact protein mass spectrometry. Sci. Rep. 4, 5797 (2014).","journal-title":"Sci. Rep."},{"key":"63444_CR57","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/bpa.12845","volume":"30","author":"M Fayyad","year":"2020","unstructured":"Fayyad, M. et al. Investigating the presence of doubly phosphorylated \u03b1-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases. Brain Pathol. 30, 831\u2013843 (2020).","journal-title":"Brain Pathol."},{"key":"63444_CR58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday, G., Hely, M., Reid, W. & Morris, J. The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol. 115, 409\u2013415 (2008).","journal-title":"Acta Neuropathol."},{"key":"63444_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2000.tb06899.x","volume":"920","author":"E G\u00f3mez-Tortosa","year":"2000","unstructured":"G\u00f3mez-Tortosa, E., Irizarry, M. C., G\u00f3mez-Isla, T. & Hyman, B. T. Clinical and neuropathological correlates of dementia with Lewy bodies. Ann. N. Y. Acad. Sci. 920, 9\u201315 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"63444_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41531-022-00388-7","volume":"8","author":"HA Lashuel","year":"2022","unstructured":"Lashuel, H. A. et al. Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity. NPJ Parkinsons Dis. 8, 136 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"63444_CR61","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/cne.24468","volume":"526","author":"V Delic","year":"2018","unstructured":"Delic, V. et al. Sensitivity and specificity of phospho-Ser129 \u03b1-synuclein monoclonal antibodies. J. Comp. Neurol. 526, 1978\u20131990 (2018).","journal-title":"J. Comp. Neurol."},{"key":"63444_CR62","doi-asserted-by":"crossref","unstructured":"Furderer, M. L. et al. A comparative biochemical and pathological evaluation of brain samples from knock-in murine models of Gaucher disease. Int. J. Mol. Sci. 25, 1827 (2024).","DOI":"10.3390\/ijms25031827"},{"key":"63444_CR63","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10354-010-0850-x","volume":"160","author":"GM Pastores","year":"2010","unstructured":"Pastores, G. M. Neuropathic Gaucher disease. Wien. Med. Wochenschr. 160, 605\u2013608 (2010).","journal-title":"Wien. Med. Wochenschr."},{"key":"63444_CR64","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s00415-024-12439-5","volume":"271","author":"G Imbalzano","year":"2024","unstructured":"Imbalzano, G. et al. Neurological symptoms in adults with Gaucher disease: a systematic review. J. Neurol. 271, 3897\u20133907 (2024).","journal-title":"J. Neurol."},{"key":"63444_CR65","doi-asserted-by":"publisher","unstructured":"Sah, S. et al. Cortical synaptic vulnerabilities revealed in a \u03b1-synuclein aggregation model of Parkinson\u2019s disease. bioRxiv https:\/\/doi.org\/10.1101\/2024.06.20.599774 (2024).","DOI":"10.1101\/2024.06.20.599774"},{"key":"63444_CR66","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580 (1991).","journal-title":"Ann. Neurol."},{"key":"63444_CR67","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","volume":"12","author":"E Bereczki","year":"2016","unstructured":"Bereczki, E. et al. Synaptic proteins predict cognitive decline in Alzheimer\u2019s disease and Lewy body dementia. Alzheimers Dement. 12, 1149\u20131158 (2016).","journal-title":"Alzheimers Dement."},{"key":"63444_CR68","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/brain\/awx352","volume":"141","author":"E Bereczki","year":"2018","unstructured":"Bereczki, E. et al. Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach. Brain 141, 582\u2013595 (2018).","journal-title":"Brain"},{"key":"63444_CR69","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.neurobiolaging.2014.06.015","volume":"35","author":"DR Whitfield","year":"2014","unstructured":"Whitfield, D. R. et al. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer\u2019s disease: association with cognitive impairment. Neurobiol. Aging 35, 2836\u20132844 (2014).","journal-title":"Neurobiol. Aging"},{"key":"63444_CR70","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/jnc.14820","volume":"150","author":"DJ Vidyadhara","year":"2019","unstructured":"Vidyadhara, D. J., Lee, J. E. & Chandra, S. S. Role of the endolysosomal system in Parkinson\u2019s disease. J. Neurochem. 150, 487\u2013506 (2019).","journal-title":"J. Neurochem."},{"key":"63444_CR71","doi-asserted-by":"publisher","unstructured":"Vidyadhara, D. J. et al. Dopamine transporter and synaptic vesicle sorting defects initiate auxilin-linked Parkinson\u2019s disease. bioRxiv https:\/\/doi.org\/10.1101\/2022.02.04.479203 (2022).","DOI":"10.1101\/2022.02.04.479203"},{"key":"63444_CR72","doi-asserted-by":"crossref","unstructured":"Leung, H. W., Foo, G. & VanDongen, A. Arc regulates transcription of genes for plasticity, excitability and Alzheimer\u2019s disease. Biomedicines 10, 1946 (2022).","DOI":"10.3390\/biomedicines10081946"},{"key":"63444_CR73","doi-asserted-by":"publisher","first-page":"108","DOI":"10.12688\/f1000research.3786.1","volume":"3","author":"J Vallortigara","year":"2014","unstructured":"Vallortigara, J. et al. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000Res 3, 108 (2014).","journal-title":"F1000Res"},{"key":"63444_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2023.1043664","volume":"17","author":"D Piromalli Girado","year":"2023","unstructured":"Piromalli Girado, D., Miranda, M., Giachero, M., Weisstaub, N. & Bekinschtein, P. Endocytosis is required for consolidation of pattern-separated memories in the perirhinal cortex. Front. Syst. Neurosci. 17, 1043664 (2023).","journal-title":"Front. Syst. Neurosci."},{"key":"63444_CR75","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0896-6273(02)00601-3","volume":"33","author":"G Di Paolo","year":"2002","unstructured":"Di Paolo, G. et al. Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice. Neuron 33, 789\u2013804 (2002).","journal-title":"Neuron"},{"key":"63444_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24548-0","volume":"12","author":"Y Ito","year":"2021","unstructured":"Ito, Y. et al. Sphingolipids mediate polar sorting of PIN2 through phosphoinositide consumption at the trans-Golgi network. Nat. Commun. 12, 4267 (2021).","journal-title":"Nat. Commun."},{"key":"63444_CR77","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.15252\/embj.201696048","volume":"36","author":"S Capasso","year":"2017","unstructured":"Capasso, S. et al. Sphingolipid metabolic flow controls phosphoinositide turnover at the trans-Golgi network. EMBO J. 36, 1736\u20131754 (2017).","journal-title":"EMBO J."},{"key":"63444_CR78","doi-asserted-by":"publisher","first-page":"19473","DOI":"10.1073\/pnas.1003308107","volume":"107","author":"PK Mistry","year":"2010","unstructured":"Mistry, P. K. et al. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc. Natl. Acad. Sci. USA 107, 19473\u201319478 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63444_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"63444_CR80","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287 (2012).","journal-title":"Omics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63444-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:04:00Z","timestamp":1758891840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63444-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63444"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63444-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5649173\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8484"}}